- Home
- TGLS vs PTCT Comparison
TGLS vs PTCT Comparison
Compare TGLS & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGLS
- PTCT
- Stock Information
- Founded
- TGLS 1984
- PTCT 1998
- Country
- TGLS Colombia
- PTCT United States
- Employees
- TGLS N/A
- PTCT N/A
- Industry
- TGLS Electronic Components
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- TGLS Consumer Discretionary
- PTCT Health Care
- Exchange
- TGLS Nasdaq
- PTCT Nasdaq
- Market Cap
- TGLS 4.0B
- PTCT 3.9B
- IPO Year
- TGLS 2012
- PTCT 2013
- Fundamental
- Price
- TGLS $75.55
- PTCT $52.13
- Analyst Decision
- TGLS Buy
- PTCT Buy
- Analyst Count
- TGLS 4
- PTCT 14
- Target Price
- TGLS $77.25
- PTCT $67.64
- AVG Volume (30 Days)
- TGLS 276.6K
- PTCT 1.2M
- Earning Date
- TGLS 08-07-2025
- PTCT 08-07-2025
- Dividend Yield
- TGLS 0.77%
- PTCT N/A
- EPS Growth
- TGLS 6.50
- PTCT N/A
- EPS
- TGLS 3.70
- PTCT 7.51
- Revenue
- TGLS $919,842,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- TGLS $14.13
- PTCT $120.38
- Revenue Next Year
- TGLS $11.12
- PTCT N/A
- P/E Ratio
- TGLS $20.42
- PTCT $6.94
- Revenue Growth
- TGLS 11.73
- PTCT 91.12
- 52 Week Low
- TGLS $46.47
- PTCT $29.02
- 52 Week High
- TGLS $90.34
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- TGLS 45.23
- PTCT 62.66
- Support Level
- TGLS $75.97
- PTCT $44.15
- Resistance Level
- TGLS $78.28
- PTCT $52.70
- Average True Range (ATR)
- TGLS 1.89
- PTCT 1.87
- MACD
- TGLS 0.27
- PTCT 0.59
- Stochastic Oscillator
- TGLS 39.09
- PTCT 93.33
About TGLS Tecnoglass Inc.
Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.